$TDOC

Bliss Kelly sold $46K of TDOC

Bliss Kelly (President, U.S. Group Health) sold 7,357 shares of Teladoc Health, Inc. (TDOC) at $6.30 on 2026-09-02.

Original reporting
SEC EDGAR · Bliss Kelly
Published Sep 3, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 4, 2026, 7:18 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TDOC
Neutral
high confidence
Mentioned
$TDOC
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TDOCNeutralLow
01

Why it matters

The sale is modest and does not suggest material insider sentiment shift.

02

Market read

Limited relevance; likely no immediate price reaction.

03

What to watch

Potential upcoming earnings or guidance that may affect insider behavior.

Relevance 3/10Novelty 4/10Timing: post‑market filing

Background

Form 4 filings disclose insider trades; investors track them for signals.

Company-level read

Ticker impact

$TDOCNeutralHigh confidence
Context

President of U.S. Group Health sold 7,357 shares for $46,356, a Form 4 filing.

Expected impact

No significant impact expected.

Evidence & confidence

Sale size is small relative to float and market cap; no pre-arranged plan.

Market effects

None; Teladoc operates in telehealth with no sector‑wide impact from this sale.

None; the transaction is company‑specific.

Minimal; only relevant to Teladoc investors.

Counterpoint

Even small insider sales can signal concerns; monitor for further disposals.

Key entities

  • Bliss Kelly

    President, U.S. Group Health at Teladoc Health.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TDOCLow

Teladoc nabs insurance veteran as new CFO

Teladoc Health appointed Michael Grasher as its new CFO, effective immediately. Grasher succeeds Mala Murthy, who left in November. He brings over 30 years of experience in insurance and financial services, most recently as CFO of IFG Companies. The move follows Teladoc's recent revenue guidance reduction, partly due to challenges in its mental health unit, BetterHelp.

$TDOCMed

Teladoc appoints insurance executive Michael Grasher as CFO

Teladoc Health named Michael Grasher as its new CFO. Grasher, with over 30 years of experience in insurance, previously served as CFO of IFG Companies. The appointment follows Teladoc's recent revenue forecast cut and challenges in its mental health unit, BetterHelp. Analyst Elizabeth Anderson views the move positively for Teladoc's leadership.

$TDOCMedAI 8/10

Teladoc Health (TDOC) Q2 2026 Earnings Call Transcript

Teladoc Health (TDOC) reported Q2 2026 revenue of $606.9 million, down 4% year over year, with BetterHelp revenue $212.6 million, down 11% due to a faster shift from cash pay to insurance. Adjusted EBITDA was $65.7 million. Full-year 2026 guidance: revenue $2.36B to $2.45B and adjusted EBITDA $271M to $303M. CEO Charles Divita said insurance demand outpaced provider capacity.